Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has granted the Company's request for continued listing on The NASDAQ Capital Market pursuant to an extension through June 3, ...

MORRISVILLE, N.C., May 16, 2013 (BUSINESS WIRE) -- Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) , today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has granted the Company's request for continued listing on The NASDAQ ...

Oxygen Biotherapeutics, Inc. ("OBI") (NASDAQ: OXBT), today announced the initiation of the second cohort of its Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte in patients with severe, non-penetrating traumatic brain ...

New York, NY - (NISMAGAZINE) - 4/28/2013- Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) gained 12.45% at $0.225 after trading 120,062 shares.

Oxygen Biotherapeutics Inc. ( OXBT ) is all set to begin enrolling patients in the second cohort of its phase IIb clinical trial to investigate the safety and tolerability of Oxycyte in patients with severe, non-penetrating traumatic brain injury.

Company Name Last PVUS$1000 [1Wk] MGC Diagnostics Corporation (MGCD) US$7.0 1,187 Vermillion (VRML) US$1.35 1,164 Oxygen Biotherapeutics (OXBT) 24.99c 1,152 Imris Inc (IMRS) US$3.19 1,150 Uroplasty, Inc. (UPI) US$2.49 1,117. Bottom 5 ...

... (UPI) keeps rising: up 21.4% in 3 days US$2.67 18c [7.2%] 0.7 Bioanalytical Systems (BASI) climbs 4.7% on below average volume US$1.55 7c [4.7%] 0.8 UPDATE: Oxygen Biotherapeutics (OXBT) keeps rising: up 17.5% in 2 days 23.50c 1.01c [4.5%] 0.5 ...

UPDATE: Oxygen Biotherapeutics (OXBT) soars 12.4% on average volume 22.49c 2.49c [12.4%] 1 UPDATE: Urologix (ULGX) soars 11.6% on strong volume 48.0c 5c [11.6%] 5.3 MGC Diagnostics (MGCD) rises to test 7.0 US$7.24 74c [11.4%] 0.4 Uroplasty (UPI ...